5305 articles
Alon Ben-Noon, CEO and co-founder of NeuroSense Therapeutics, a clinical-stage biotechnology company focused on treatments for neurodegenerative disease
Lisa Jones-Engel, Senior Science Advisor on primate experimentation with People for the Ethical Treatment of Animals (PETA) discusses her prior work wit...
Neil Skolnik, MD, Professor of Family and Community Medicine at Jefferson Health and practicing primary care physician discusses chronic kidney disease ...
Melissa Rogne, Founder and President of Chapter Aesthetic Studio discusses their expansion over the next two years with a unique focus on communities wh...
is a Senior Director, Global Compound Development Team Leader for the Neuroscience Therapeutic Area at Janssen Research & Development, LLC.
Afsaneh Barzi, MD, PhD, associate professor of gastrointestinal oncology at City of Hope discusses advancements in treating colorectal cancer (CRC), esp...
Sumanta (“Monty”) Pal, Professor, Department of Medical Oncology & Therapeutics Research; Co-director, Kidney Cancer Program at City of Hope, a canc...
In the coming months, the FDA is expected to finalize its proposed rule to make certain hearing aids available over the counter, which will allow consum...
Eleni Efstathiou, MD, PhD, Section Chief of Genitourinary Medical Oncology at Houston Methodist Oncology Partners and an investigator on the Phase...
Mitzi Joi Williams, board-certified neurologist, fellowship-trained multiple sclerosis specialist and Founder and CEO of the Joi Life Wellness Group Mul...